Bioquell Share Discussion Threads

[tp100] 13/9/2006 09:55

something is happening here.

[525bmw] 12/9/2006 15:37

cymbelline

I would expect an RNS if they were the company involved.

[cymbelline] 12/9/2006 15:02

Yes it was, 525, there's a very similar article on the Bioquell website which mentions Bioquell.

There's also the article below re Avian Flu, presumably for marketing purposes. Like so many other small companies they could do with some decent PR, surely the ability to tackle Avian flu contamination warranted an RNS release?

I'm just trying to find out why the price just hiked up 2p on no trades. It moved up 1p on a 25k trade earlier but suddenly put 2p more on. I bought my first tranche in the hope of some announcement in the next few days.




Last Updated: 08/09/06

Corporate Contingency Planning for Avian Flu and Environmental Control in the Office

Avian Flu (H5N1) can be eradicated from the working environment using BIOQUELL's unique Room Bio-decontamination Service (RBDS) and Clarus® Hydrogen Peroxide Vapour technology. The service is regularly used in hospitals around the world for the control of MRSA, Clostridium difficile, and many other micro-organisms.



Act now to ensure that your staff are protected from environmental contamination at work should the H5N1 pandemic occur.
Help secure your business survival by reducing the risk of mass sickness in your workforce.
Bio security, plan your emergency response now.
Receive priority service in the event of an outbreak.

The spread of Avian Flu around the world is much in the media at the moment, leading to justifiable fears of a possible pandemic – or global outbreak, should the virus transfer from human to human.

While this would require a mutation of the virus, recent evidence gathered from cases in Turkey indicates that some degree of mutation has already occurred. It is entirely possible that further changes could take place, increasing the risk of human to human cross infection and leading to the long threatened pandemic.

Bio Security in the Corporate environment

The modern office, open plan and centrally heated with high population density offers a near ideal environment for a virus to flourish and spread. Bio-decontamination of such areas, including all manner of sensitive electronic equipment has long been near impossible to achieve. However, BIOQUELL's RBDS system achieves a fully certified sterile* environment within hours. No equipment or furnishings are damaged and no residues remain to cause unpleasant odours or other associated issues.

Historical precedents exist to show the potential threat to humans from these virulent flu types. The 1918 – 19 Spanish Flu virus is widely considered the most deadly disease in history, killing 40 million people in a matter of months. The virus is now believed to have come from birds, by scientists who also believe that it bore similarities to H5N1, the strain currently responsible for deaths around the world.

[525bmw] 06/9/2006 16:20

Obviously not as the share price has dropped...

[525bmw] 05/9/2006 20:57

Has this anything to do with BQE...

[nashwan123] 03/9/2006 10:34

Things obviously very quiet at BQE. I expect results to be announced towards end of this month. This should offer some positive numbers and data on decontamination trials and wound treatment/commercial tie ups. No real direction on the chart for me at this juncture though.

[davebowler] 27/7/2006 12:18

Anybody looked at the MRSA connection with Manuka Honey via William Ransom-RNSM?

[mr_chaps] 03/7/2006 14:58

anyone still following this? large spike in December 05 followed by a steady decline down to last year's low of ~100p

[tp100] 07/6/2006 12:37

kidney - I agree that this BB is a little quiet. A few buyers today though.My understanding is that their other businesses show lots of potential especially the "wound management" division . The profitable division subsidises the R&D until it is then spun off. Looks an interesting 12 month play.

[nashwan123] 25/5/2006 23:30

RSI in oversold territory and hope that price will rebound a couple of pence with slightly better market sentiment following this past weeks major retracement. Bird flu in Asia sadly might put BQE back on the City radar.

[kidney] 10/5/2006 14:22

Surprised at the lack of activity on this bb.
I looked over the results today and decided that I had'nt realised how many things Bioquell are into.Also I was unaware that they are concentrating on the American market,so any problems with the British NHS should'nt upset their overall plan.
Most pi's,like meself most likely imagine that BQE is into hospital cleaning.I suggest that you have a look at all the other businesses that they are involved in.Would like to buy at 100p,but if this recent increase in momentum carries the share price past 130p and the averages look better,then I shall buy with a target of 160p in the near term.
DYOR and LOL

[scotswhaehae] 10/4/2006 15:45

re post 198...The figures were not on 6 Apr...they were on 11 Apr 2005 as it happens...

interims suggested strong progress...likely this will have stepped up further...

definite buyers sniffing around imho..

set fair for a big rise imho...

great stuff!

[cymbelline] 10/4/2006 07:43

Largest trade on Friday was 5k, so if MMs were buying they can't be expecting to shift many. They were all ordinary trades anyway. All 6 of them. I'd be more confident with higher volume on this rise, doesn't feel sustainable.

I'm a bit concerned by results not seeming to be imminent. They were on 6th April last year but there's no sign of them in the next fortnight's calendar on afx. They may be of course be awaiting some contract news before reporting but if there was anything definite they'd be more likely to post results on time with a hint of contract news to come, imo.

[nashwan123] 07/4/2006 16:28

MMs buying this afternoon- good vibes

[scotswhaehae] 07/4/2006 11:35

Yep ..we have buyers sniffing imho...

Contract news...and these are 140p plus imho!

Great stuff!

[nashwan123] 06/4/2006 19:03

Finals should be out in the next week and if orders are as good as expected then should give a boost to flagging SP,

[mach10] 05/4/2006 19:20

I don't think it is a problem so much with the product as the NHS to be honest. They already are active in the States and France. I think Bqe offered to do a hospital for £12000 last yearor two and the director refused! But other companies are in the same boat and maybe not so advanced as BQE. I think the NHS is in trouble anyway so may not be the market it promised. BQE last results were highly promising with record order books so maybe the MRSA angle is the icing on the cake and not the cake itself.

[pugugly] 05/4/2006 10:15

March10:. Agreed IF and it is a very big IF they can obtain contracts. Their anti infective product seems to have been around for a long time with no purchases. The quesstion is Why? Management scientists not salesmen? or undisclosed fundamental problems?

[mach10] 04/4/2006 20:29

I disagree Pug! These are cheap now as they are not a one trick pony IMHO. But it is so hard to call the bottom of these. They may have further to fall-10 to 20% but the upside is huge as these will hit 160 if they can get some NHS or more American contracts.They are probably the best MRSA company around,they just need to deliver.

[pugugly] 04/4/2006 15:22

Just had a look at these as my broker was keen on them at 140p. Cannot see any reason to buy. based on REFS last net real assets were only 13.7p per share
Loss making and losses increasing y on y. Turnover down y on y at interims.

Comments?

[bookbroker] 04/4/2006 15:07

The board should not have issued a statement, all it has done is send the share price spiralling down.

[cymbelline] 01/4/2006 10:57

This has nothing to do with BQE at present, may never have. They use vapourised H202 and I don't know how different that is from microaerosolized H202. Also, this article is dated 1994.

But it's food for thought.


Title: The effect of microaerosolized hydrogen peroxide on bacterial and viral poultry pathogens.
Authors: Neighbor, NK; Newberry, LA; Bayyari, GR; Skeeles, JK; Beasley, JN; McNew, RW
Source: Poult Sci 1994 Oct; 73 (10): 1511-6
Year: 1994

Language: eng

Summary: The effect of microaerosolized H2O2 on bacterial and viral poultry pathogens was investigated. Bacterial cultures and viruses were dried on sterile glass Petri dishes and subjected to direct and indirect 5% (H2O2) microaerosol mist.

In the trials using Escherichia coli and Staphylococcus aureus, there was complete inactivation following exposure to H2O2. Using Salmonella typhimurium, indirect exposure resulted in only partial inactivation whereas direct exposure to H2O2 gave complete inactivation.

For the viruses studied, 5% H2O2 microaerosol mist completely inactivated infectious laryngotracheitis virus. Newcastle disease virus, infectious bronchitis virus, and avian influenza virus showed reduced infectivity but were not completely inactivated.

Avian reovirus susceptibility varied with the method of exposure and infectious bursal disease virus was highly resistant. The use of 10% H2O2 mist, however, resulted in total inactivation of infectious bursal disease virus. The effect of 10% H2O2 on equipment and selected materials representative of a hatcher or poultry house was investigated. A solar cell calculator, a thermostat containing a microswitch, and samples of uncoated steel, galvanized steel, and uncoated aluminum were subjected to 10 fumigation cycles. No damage was detected in the calculator and the thermostat. Both the uncoated steel and the galvanized steel showed signs of oxidation. The aluminum did not show signs of oxidation.

[scotswhaehae] 24/3/2006 10:42

Didn't take long to retrace...!

Same old story!